Formosa Pharmaceuticals Revenue

In the year 2025, Formosa Pharmaceuticals had annual revenue of 9.50M TWD, down -93.38%. Formosa Pharmaceuticals had revenue of 3.23M in the quarter ending December 31, 2025, a decrease of -45.28%.

Revenue

9.50M

Revenue Growth

-93.38%

P/S Ratio

442.04

Revenue / Employee

n/a

Employees

n/a

Market Cap

4.20B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.50M	-133.86M	-93.38%
Dec 31, 2024	143.36M	112.18M	359.89%
Dec 31, 2023	31.17M	29.86M	2,270.49%
Dec 31, 2022	1.32M	-27.21M	-95.39%
Dec 31, 2021	28.53M	-	-
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sagittarius Life Science	346.08M
OBI Pharma	58.58M
ACRO Biomedical	36.50M
Energenesis Biomedical CO.,LTD.	7.67M
Senhwa Biosciences	1.07M
BioGend Therapeutics	222.34M
Medigen Biotechnology	1.58B
Pharmosa Biopharm	67.27M

Revenue Rankings